期刊文献+

二膦酸盐在类风湿性关节炎中的应用进展 被引量:3

下载PDF
导出
出处 《中国矫形外科杂志》 CAS CSCD 北大核心 2008年第13期1001-1003,共3页 Orthopedic Journal of China
  • 相关文献

参考文献29

  • 1张义浜,刘志敏,熊凌霜.类风湿关节炎发病机制及其治疗方法研究进展[J].细胞与分子免疫学杂志,2005,21(B03):88-90. 被引量:65
  • 2陈敏,史久华.类风湿性关节炎治疗近展[J].国外医学(预防.诊断.治疗用生物制品分册),2000,23(3):119-121. 被引量:2
  • 3冯芳.类风湿性关节炎治疗最新进展[J].药物生物技术,2005,12(1):58-61. 被引量:7
  • 4Lodder MC, Van Pelt PA, Lems WF, et al. Effects of high dose Ⅳ pamidronate on disease activity and bone metabolism in patients with active RA : a randomized, double - blind, placebo - controlled trial [J]. J Rheumatol, 2003, 30: 2080- 2081.
  • 5Fieisch H, Russell RGG, Straumann F. Effect of pyrophosphate on hydroxyapatite and its complications in calcium homeostasis [ J ]. Nature, 1966, 212 : 901 -903.
  • 6Graham R, Russell G. Bisphosphonates: mode of action and pharmacology[JJ. Pediatrics, 2007, 119:150 - 162.
  • 7Lambrinoudaki I, Chritodoulakos G. Bisphosphonates [ J ]. Ann N Y Acad Sci, 2006, 1092:397-402.
  • 8牟健雄,沈彬.二磷酸盐骨科临床应用的研究进展[J].中国矫形外科杂志,2007,15(1):42-45. 被引量:4
  • 9Maccagno A, Di Giorgio E, Roldan EJ, et al. Double blind radiological assessment of continuous oral pamidronic acid in patients with rheumatoid arthritis[ J]. Scand J Rheumatol, 1994, 23 : 211 - 214.
  • 10Bendele AM. Models of rheumatoid arthritis[ J]. J Musculoskel Neuro Interact, 2001, 1: 377 -385.

二级参考文献80

  • 1Saay K, Koehnke R,Caldwell 3, et al. Low-dose Long-term Corticosteroid Therapy in Rheumatoid Arthritis:an Analysis of Serious Adverse Effects[J]. AM 3 med, 1994, (96): 115.
  • 2Stancikova M, Stancik R, Gubzova Z,et al. Collagen in the treatment of rheumatic diseases-oral tolerance[J]. Bratisl Lek Listy, 1999, 100(10) : 567.
  • 3Willis D, Moore AR, Gowland G, et al. OM-89 modulation of chronic inflammation: relevance to clinical use[J]. Br J Rheumatol, 1995, 34(6): 525.
  • 4New patent for manufacture of Anergen's AnergiX pharmaceutical compounds [ Drug News ] [ C ]. Investigational Drugs daily highlights, 1998,4(8): 10.
  • 5]Anergen's RA vaccine safe and well-tolerated in phase Ⅱ tri als [Drug News] [C]. Investigational Drugs daily highlights, 1997,11(11): 12.
  • 6Initiation of IR-501 rheumatoid arthritis clinical trial [Drug News][C]. Investigational Drugs daily highlights, 1998,19(8):14.
  • 7Sharma A,Davis CB,Tobia LA, et al. Comparative pharmacodynamics of keliximab and clenoliximab in transgenic mice bearing human CD4[J]. J Pharmacol Exp Ther, 2000, 293(1):33.
  • 8Martin J, Glennie and Peter W M Johnson. Clinical trials of antibody therapy[J]. Immunology Today, 2000, 21(8):403.?A?A?A
  • 9Salomon B, Bluestone J A. Complexities of CD28/B7: CTLA-4 Costimulatory Pathways in Autoimmunity and Transplantation[J]. Annual Review of Immunology, 2001, 19(4) :225.
  • 10Emilia Quattrocchi, Margaret J. Dallman and Marc Feldmann. Adenovirus-Mediated Gene Transfer of CTLA-4Ig Fusion Protein in the Suppression of Experimental Autoimmune Arthritis [J]. Arthritis & Rheumatism, 2000, 43 (8): 1688.

共引文献74

同被引文献40

引证文献3

二级引证文献19

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部